| Literature DB >> 29702602 |
Amr El-Demerdash1,2, Céline Moriou3, Jordan Toullec4, Marc Besson5,6, Stéphanie Soulet7, Nelly Schmitt8, Sylvain Petek9, David Lecchini10, Cécile Debitus11, Ali Al-Mourabit12.
Abstract
Herein, we describe the isolation and spectroscopic identification of eight new tetrabrominated tyrosine alkaloids 2⁻9 from the Polynesian sponge Suberea ianthelliformis, along with known major compound psammaplysene D (1), N,N-dimethyldibromotyramine, 5-hydroxy xanthenuric acid, and xanthenuric acid. Cytotoxicity and acetylcholinesterase inhibition activities were evaluated for some of the isolated metabolites. They exhibited moderate antiproliferative activity against KB cancer cell lines, but psammaplysene D (1) displayed substantial cytotoxicity as well as acetylcholinesterase inhibition with IC50 values of 0.7 μM and 1.3 μM, respectively.Entities:
Keywords: Suberea ianthelliformis; acetylcholinesterase inhibition; brominated tyrosine alkaloids; cytotoxicity
Mesh:
Substances:
Year: 2018 PMID: 29702602 PMCID: PMC5983277 DOI: 10.3390/md16050146
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1Structures of isolated compounds 1–12.
Figure 2COSY and key HMBC correlations for psammaplysenes F (2) and G (3).
1H NMR (500 MHz) and 13C NMR (125 MHz) data for Psammaplysenes F (2) and G (3) in CD3OD.
| Position | Psammaplysene F (2) | Psammaplysene G (3) | ||||
|---|---|---|---|---|---|---|
| No. | HMBC | HMBC | ||||
| 1 | 154.10, C | - | - | 153.29/153.04, C | - | - |
| 2 | 112.80, C | - | - | 112.49, C | - | - |
| 3 | 133.09/133.01, CH | 7.78/7.70, s | 1, 2, 5, 6, 7 | 133.70/133.42, CH | 7.53/7.54, s | 1, 2, 5, 6, 7 |
| 4 | 130.98, C | - | - | 130.70/131.16, C | - | - |
| 5 | 133.09/133.01, CH | 7.78/7.70, s | 1, 2, 3, 6, 7 | 133.70/133.42, CH | 7.53/7.54, s | 1, 2, 3, 6, 7 |
| 6 | 112.80, C | - | - | 112.49, C | - | - |
| 7 | 140.89/141.19, CH | 7.36–7.39/7.35–7.38, d (15.5) | 3, 4, 5, 9 | 132.24/132.49, CH | 6.49–6.52/6.56–6.58, d (12.5) | 3, 4, 5, 9 |
| 8 | 118.90/118.72, CH | 7.11–7.15/6.99–7.02, d (15.5) | 4, 7, 9 | 123.90/124.59, CH | 6.13–6.16/6.09–6.12, d (12.5) | 4, 7, 9 |
| 9 | 168.96/168.80, C | - | - | 171.13/171.01, C | - | - |
| 10 | 48.20/47.14, CH2 | 3.89/3.74, t (7.2) | 9, 11, 12, 21 | 48.97/45.75, CH2 | 3.65/3.73, t (7.5) | 9, 11, 12, 21 |
| 11 | 30.86/29.16, CH2 | 2.22/2.16, m | 10, 12 | 29.32/28.68, CH2 | 2.02/2.18, m | 10,12 |
| 12 | 71.94/72.64, CH2 | 4.11/4.05, t (6.4) | 10, 11, 13 | 72.03/72.32, CH2 | 3.78/4.04, t (6.5) | 10, 11, 13 |
| 13 | 153.88/153.94, C | - | - | 153.55/153.86, C | - | - |
| 14 | 119.57, C | - | - | 119.36/119.59, C | - | - |
| 15 | 134.63/134.56, CH | 7.57, br s | 13, 14, 17, 18, 19 | 134.51/134.57, CH | 7.51/7.56, s | 13, 14, 17, 18, 19 |
| 16 | 136.81/136.99, C | - | - | 136.85, C | - | - |
| 17 | 134.63/134.56, CH | 7.57, br s | 13, 14, 15, 18, 19 | 134.51/134.57, CH | 7.51/7.56, s | 13, 14, 15, 18, 19 |
| 18 | 119.57, C | - | - | 119.36/119.59, C | - | - |
| 19 | 30.45, CH2 | 3.00, m | 15, 16, 17, 20, 22, 23 | 30.51/30.56, CH2 | 3.00, m | 15, 16, 17, 20, 22, 23 |
| 20 | 59.24, CH2 | 3.30, m | 16, 19, 22, 23 | 59.32/59.24, CH2 | 3.34, m | 16, 19, 22, 23 |
| 21 | 34.74/36.55, CH3 | 3.09/3.28, s | 9, 10 | 32.59/36.67, CH3 | 3.06/3.03, s | 9, 10 |
| 22 | 43.62, CH3 | 2.91, s | 20, 23 | 43.70/43.73, CH3 | 2.91, s | 20, 23 |
| 23 | 43.62, CH3 | 2.91, s | 20, 22 | 43.70/43.73, CH3 | 2.91, s | 20, 22 |
a Chemical shifts are given for both rotamers when distinguishable signals were identified.
1H NMR (500 MHz) and 13C NMR (125 MHz) data for Psammaplysenes H (4) and I (5) in CD3OD.
| Position | Psammaplysene H (4) | Psammaplysene I (5) | ||||
|---|---|---|---|---|---|---|
| No | HMBC | HMBC | ||||
| 1 | 154.7, C | - | - | 154.7, C | - | - |
| 2 | 119.6, C | - | - | 119.6, C | - | - |
| 3 | 133.5/133.4, CH | 7.92/7.85, d | 1, 2, 5, 6, 7 | 133.5/133.4, CH | 7.92/7.85, d | 1, 2, 5, 6, 7 |
| 4 | 136.2, C | - | - | 136.2, C | - | - |
| 5 | 133.5/133.4, CH | 7.92/7.85, d | 1, 2, 3, 6, 7 | 133.5/133.4, CH | 7.92/7.85, d | 1, 2, 3, 6, 7 |
| 6 | 119.6, C | - | - | 119.6, C | - | - |
| 7 | 140.2/140.0, CH | 7.40–7.44, m | 3, 4, 5, 9 | 140.2/140.0, CH | 7.40–7.44, m | 3, 4, 5, 9 |
| 8 | 121.6/121.7, CH | 7.14–7.27, dd (15.0) | 4, 7, 9 | 121.6/121.7, CH | 7.14–7.27, dd (15.0) | 4, 7, 9 |
| 9 | 168.5, C a | - | - | 168.5, C a | - | - |
| 10 | 48.4/47.3, CH2 | 3.91/3.76, t (7.0) | 9, 11, 12, 21 | 48.4/47.3, CH2 | 3.91/3.76, t (7.0) | 9, 11, 12, 21 |
| 11 | 30.6/29.1, CH2 | 2.23/2.17, m | 10, 12 | 30.6/29.1, CH2 | 2.23/2.17, m | 10, 12 |
| 12 | 72.6/71.9, CH2 | 4.12/4.07, m | 10, 11, 13 | 72.6/71.9, CH2 | 4.12/4.07, m | 10, 11, 13 |
| 13 | 154.7, C | - | - | 154.7, C | - | - |
| 14 | 119.6, C | - | - | 119.6, C | - | - |
| 15 | 134.5, CH | 7.56/7.53, m | 13, 14, 17, 18, 19 | 134.5, CH | 7.56/7.53, m | 13, 14, 17, 18, 19 |
| 16 | 137.8, C b | - | - | 137.8, C b | - | - |
| 17 | 134.5, CH | 7.56/7.53, m | 13, 14, 15, 18, 19 | 134.5, CH | 7.56/7.53, m | 13, 14, 15, 18, 19 |
| 18 | 119.6, C | - | - | 119.6, C | - | - |
| 19 | 32.2, CH2 | 2.93, t (8.0) | 16, 20, 22 | 32.2, CH2 | 2.93, t (8.0) | 16, 20, 22 |
| 20 | 51.1, CH2 | 3.21, m | 16, 19, 22 | 51.1, CH2 | 3.21, m | 16, 19, 22 |
| 21 | 34.7/36.6, CH3 | 3.10/3.29, s | 9, 10 | 34.7/36.6, CH3 | 3.10/3.29, s | 9, 10 |
| 22 | 34.0, CH3 | 2.70, s | 20 | 34.0, CH3 | 2.70, s | 20 |
| 1′ | 57.2, CH2 | 3.27, m | 1, 2′, 3′ | 48.7, CH2 | 3.35, m | 1, 2′, 3′ |
| 2′ | 27.6, CH2 | 2.23, m | 1′, 3′ | 30.9 CH2 | 2.23, m | 1′, 3′ |
| 3′ | 71.9, CH2 | 4.18, m | 1′, 2′, 4′, 5′ | 71.9, CH2 | 4.18, m | 1′, 2′, 4′ |
| 4′ | 44.3, CH3 | 2.78/2.74, s | 3′, 5′ | 34.0, CH3 | 2.77/2.76, s | 3′ |
| 5′ | 44.3, CH3 | 2.79/2.74, s | 3′, 4′ | - | - | - |
a Chemical shifts are given for both rotamers when distinguishable signals were identified; b Detected by HMBC correlations.
Figure 3COSY and key HMBC correlations for psammaplysenes H (4) and I (5).
1H NMR (500 MHz) and 13C NMR (125 MHz) data for Anomoians C (6) and D (7) in CD3OD.
| Position | Anomoian C (6) | Anomoian D (7) | ||||
|---|---|---|---|---|---|---|
| No | HMBC | HMBC | ||||
| 1 | 151.65/151.47, C | - | - | 152.7, C | - | - |
| 2 | 112.36, C | - | - | 112.69, C | - | - |
| 3 | 134.47/134.41, CH | 7.34/7.32, s | 1, 2, 4, 5, 6, 7 | 134.40, CH | 7.37/7.35, s | 1, 2, 4, 5, 6, 7 |
| 4 | 132.77/133.49, C | - | - | 130.53/129.90, C | - | - |
| 5 | 134.47/134.41, CH | 7.34/7.32, s | 1, 2, 3, 4, 6, 7 | 134.40, CH | 7.37/7.35, s | 1, 2, 3, 4, 6, 7 |
| 6 | 112.36, C | - | - | 112.69, C | - | - |
| 7 | 33.14/32.14, CH2 | 2.90/2.83–2.99, m | 3, 4, 5, 8, 9 | 37.40/38.02, CH2 | 2.83–3.04/2.92, m | 3, 4, 5, 8, 9 |
| 8 | 66.86, CH | 3.82, m | 7, 9, 24, 25 | 60.79/61.29, CH | 4.26/4.17, m | 7, 9, 24 |
| 9 | 172.36/172.63, C | - | - | 171.40/172.00, C | - | - |
| 10 | 47.14/48.24, CH2 | 3.40–3.72, m | 9, 11, 21 | 47.67/47.78, CH2 | 3.48–3.80/3.26–3.51, m | 9, 11, 21 |
| 11 | 29.09/30.45, CH2 | 1.92–2.00/1.73–1.92, m | 10, 12 | 29.15/30.50, CH2 | 1.95–2.05/1.95, m | 10, 12 |
| 12 | 72.31/71.72, CH2 | 3.85–3.93/3.88, m | 11, 13 | 72.35/71.61, CH2 | 3.97/3.99, m | 11, 13 |
| 13 | 153.61/153.30, C | - | - | 153.72, C | - | - |
| 14 | 119.43, C | - | - | 119.47, C | - | - |
| 15 | 134.47/134.50, CH | 7.52/7.53, s | 13, 14, 16, 17, 18, 19 | 134.51/134.53, CH | 7.54/7.55, s | 13, 14, 16, 17, 18, 19 |
| 16 | 137.97/138.24, C | - | - | 137.72, C | - | - |
| 17 | 134.47/134.50, CH | 7.52/7.53, s | 13, 14, 15, 16, 18, 19 | 134.51/134.53, CH | 7.54/7.55, s | 13, 14, 15, 16, 18, 19 |
| 18 | 119.43, C | - | - | 119.47, C | - | - |
| 19 | 31.40/31.46, CH2 | 2.92, m | 15, 16, 17, 20 | 31.22, CH2 | 2.93, m | 15, 16, 17, 20 |
| 20 | 60.12/60.14, CH2 | 3.08, m | 16, 19, 22, 23 | 59.96, CH2 | 3.21, m | 16, 19, 22, 23 |
| 21 | 36.64/34.26, CH3 | 2.92/2.93, s | 9, 10 | 36.25/34.29, CH3 | 2.50/2.47, s | 9, 10 |
| 22 | 44.30/44.34, CH3 | 2.72/2.71, s | 20, 23 | 44.18/44.21, CH3 | 2.74/2.74, s | 20, 23 |
| 23 | 44.30/44.34, CH3 | 2.72/2.71, s | 20, 22 | 44.18/44.21, CH3 | 2.74/2.74, s | 20, 22 |
| 24 | 42.31/41.19, CH3 | 2.45/2.42, s | 8, 25 | 33.26/33.68, CH3 | 2.82/3.00, s | 8 |
| 25 | 42.31/41.19, CH3 | 2.45/2.42, s | 8, 24 | - | - | - |
aChemical shifts are given for both rotamers when distinguishable signals were identified.
Figure 4COSY and key HMBC correlations for anomoians C (6) and D (7).
1H NMR (500 MHz) and 13C NMR (125 MHz) data for Anomoians E (8) and F (9) in CD3OD.
| Position | Anomoian E (8) | Anomoian F (9) | ||||
|---|---|---|---|---|---|---|
| No | HMBC | HMBC | ||||
| 1 | 153.29/153.15, C | - | - | 152.76/152.57, C | - | - |
| 2 | 119.08.119.14, C | - | - | 118.92, C | - | - |
| 3 | 135.35/135.19, CH | 7.51/7.48, s | 1, 2, 5, 6, 7 | 135.32/135.22, CH | 7.51/7.48, s | 1, 2, 5, 6, 7 |
| 4 | 137.14/138.15, C | - | - | 138.66/137.72, C | - | - |
| 5 | 135.35/135.19, CH | 7.51/7.48, s | 1, 2, 3, 6, 7 | 135.32/135.22, CH | 7.51/7.48, s | 1, 2, 3, 6, 7 |
| 6 | 119.08.119.14, C | - | - | 118.92, C | - | - |
| 7 | 38.03/38.65, CH2 | 2.84–3.03/2.93, m | 3, 4, 5, 8, 9 | 33.05/31.91, CH2 | 3.00/2.92–3.07, m | 3, 4, 5, 8, 9 |
| 8 | 60.72/61.23, CH | 4.15/4.06, m | 4, 7, 9, 24 | 66.58/66.79, CH | 3.97/3.89, m | 4, 7, 9, 24, 25 |
| 9 | 172.73/173.46, C | - | - | 172.10/171.65, C | - | - |
| 10 | 47.57/47.82, CH2 | 3.51–3.76/3.26–3.60, m | 9, 11, 12, 21 | 48.26/47.36, CH2 | 3.41–3.74/3.51–3.64, m | 9, 11, 12, 21 |
| 11 | 29.16/30.64, CH2 | 1.95–2.03/1.95, m | 10, 12 | 30.71/29.08, CH2 | 1.69–1.98/1.90–1.98, m | 10, 12 |
| 12 | 72.36/71.71, CH2 | 3.99, m | 10, 11, 13 | 71.82/72.40, CH2 | 3.94/3.95, m | 10, 11, 13 |
| 13 | 153.54, C | - | - | 153.77/153.51, C | - | - |
| 14 | 119.42, C | - | - | 119.52, C | - | - |
| 15 | 134.54/134.52, CH | 7.55/7.56, s | 13, 14, 17, 18, 19 | 134.57/134.60, CH | 7.57/7.58, s | 13, 14, 17, 18, 19 |
| 16 | 137.74/138.52, C | - | - | 137.28, C | - | - |
| 17 | 134.54/134.52, CH | 7.55/7.56, s | 13, 14, 15, 18, 19 | 134.57/134.60, CH | 7.57/7.58, s | 13, 14, 15, 18, 19 |
| 18 | 119.42, C | - | - | 119.52, C | - | - |
| 19 | 31.31/31.41, CH2 | 2.93, m | 15, 16, 17, 20 | 30.67/30.59, CH2 | 2.99, m | 15, 16, 17, 20 |
| 20 | 60.01/60.08, CH2 | 3.09, m | 16, 19, 22, 23 | 59.43, CH2 | 3.26, m | 16, 19, 22, 23 |
| 21 | 36.24/34.33, CH3 | 2.88/2.99, s | 9, 10 | 34.31/36.64, CH3 | 2.92/2.94, s | 9, 10 |
| 22 | 44.19/44.24, CH3 | 2.73/2.71, s | 20, 23 | 43.75, CH3 | 2.85/2.85, s | 20, 23 |
| 23 | 44.19/44.24, CH3 | 2.73/2.71, s | 20, 22 | 43.75, CH3 | 2.85/2.85, s | 20, 22 |
| 24 | 33.71/34.11, CH3 | 2.42/2.39, s | 4, 8 | 42.23/42.07, CH3 | 2.51/2.45, s | 4, 8, 25 |
| 25 | - | - | - | 42.23/42.07, CH3 | 2.51/2.45, s | 4, 8, 24 |
| 1′ | 71.66/71.62, CH2 | 4.09, m | 1, 2′, 3′ | 71.44, CH2 | 4.01, t (5.5) | 1, 2′, 3′ |
| 2′ | 26.95, CH2 | 2.25, m | 1′, 3′ | 26.62, CH2 | 2.27, m | 1′, 3′ |
| 3′ | 57.15, CH2 | 3.36, m | 1′, 2′, 4′, 5′ | 57.07, CH2 | 3.45, m | 1′, 2′, 4′, 5′ |
| 4′ | 44.05, CH3 | 2.85, s | 3′, 5′ | 43.79, CH3 | 2.92/2.91, s | 3′, 5′ |
| 5′ | 44.05, CH3 | 2.85, s | 3′, 4′ | 43.79, CH3 | 2.92/2.91, s | 3′, 4′ |
a Chemical shifts are given for both rotamers when distinguishable signals were identified.
Figure 5COSY and key HMBC correlations for anomoians E (8) and F (9).
Cytotoxic activities in vitro (KB Cell Line) for compounds 1–3, 6–11.
| Compounds | 10 μM a | 1 μM a |
|---|---|---|
| Psammaplysene D ( | 100 ± 0.2 | 95 ± 0.5 |
| Psammaplysene F ( | 73 ± 2 | 20 ± 0.2 |
| Psammaplysene G ( | 75 ± 0.4 | 17 ± 1 |
| Anomoian C ( | 28 ± 5 | 15 ± 3 |
| Anomoian D ( | 29 ± 2 | 17 ± 2 |
| Anomoian E ( | 82 ± 1 | 6 ± 2 |
| Anomoian F ( | 100 ± 0.5 | 20 ± 0.6 |
| 100 ± 1 | 89 ± 1 | |
| 5-hydroxy xanthenuric acid ( | 25 ± 1 | 6 ± 0.5 |
a Cell proliferation was measured with Celltiter 96 Aqueous One solution reagent (Promega), and results are expressed as the percentage of inhibition of cellular proliferation of KB cells treated for 72 h with compounds compared to cells treated with DMSO only (mean ± SE of triplicate).
Figure 6Number of bites on coral pieces per A. triostegus recruit and per hour. Error bars represent standard deviation of the mean (N = 6). ** p < 0.01.
Figure 7(a) AChE activity, U·mg−1, after 1 h exposure to 100 µg/mL of Psammalysene D (1). Boxplot distribution was made with 5 fish (N = 5). * p < 0.05; (b) AChE activity, U·mg−1, after 72 h exposure to 5 µg/mL of crude extract. Boxplot distribution was made with 5 fish (N = 5).
AChE inhibition of bromotyrosine compounds isolated from Verongiida sponges.
| Sponge/Compounds | AChE Origin Activities | Ref. | |
|---|---|---|---|
| Eel | Olatunji et al. 2014 [ | ||
| Human recombinant AchE | Sirimangkalakitti et al. 2015 [ | ||
| Unidentified | Eel | Insect recombinant | Sepcic et al. 2001 [ |
a NCI: non competitive inhibition; b CI: competitive inhibition; c ND: non described.